GSDMD and gastric cancer: Conversely, GSDMD reportedly attenuates the transition from the S to G2/M phases of the cell cycle, which results in cell cycle arrest in the gastric cancer cell line BGC823 through the downregulation of cyclinA2 and CDK2.